|
Zinc dysregulation as a druggable target in human skin photocarcinogenesis
|
1R03CA230949-01
|
$73,677
|
|
WONDRAK, GEORG
|
UNIVERSITY OF ARIZONA
|
|
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
|
5R25CA221738-02
|
$409,851
|
|
DECAPRIO, JAMES
|
DANA-FARBER CANCER INST
|
|
Yale SPORE in Skin Cancer
|
2P50CA121974-11A1
|
$2,500,000
|
|
BOSENBERG, MARCUS
|
YALE UNIVERSITY
|
|
Yale SPORE in Skin Cancer
|
2P50CA121974-11A1
|
$2,500,000
|
$2,500,000
|
BOSENBERG, MARCUS
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-05
|
$700,035
|
$35,002
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
Xeroderma Pigmentosum
|
ZIA CP010187 10777
|
$31,377
|
$6,275
|
Achatz, Maria Isabel
|
DCEG (NCI)
|
|
Workshop on Techniques in Modeling Human Cancer in Mice
|
5R25CA172010-05
|
$72,606
|
|
THREADGILL, DAVID
|
JACKSON LABORATORY
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Womens Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S3
|
$175,562
|
$28,090
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
5K08CA218460-02
|
$106,531
|
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-05
|
$542,950
|
$40,721
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
$2,917
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$8,019
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$9,360
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$102,960
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
5P50CA211024-02
|
$2,283,108
|
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
WEE1 inhibition and tumor immunity
|
1R01CA222963-01A1
|
$446,500
|
|
ZHANG, BIN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Web-based Physical Activity Intervention for Children with ALL
|
5R01CA193478-03
|
$826,706
|
|
NESS, KIRSTEN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Washington Womens Interagency HIV/AIDS Study
|
3U01AI034994-24S1
|
$106,140
|
|
KASSAYE, SEBLE
|
GEORGETOWN UNIVERSITY
|
|
Vitamin D Deficiency Leads to Increased Intra-Prostatic Androgens in African American Men
|
1R21CA231610-01
|
$208,670
|
|
NONN, LARISA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-04S1
|
$51,381
|
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-04S2
|
$57,310
|
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
|
1T32CA217834-01A1
|
$241,750
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-04
|
$334,911
|
$100,473
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Vermont Breast Cancer Molecular Characterization Laboratory
|
5U01CA196383-04
|
$312,000
|
|
STEIN, JANET
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-03S2
|
$65,611
|
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S1
|
$218,356
|
$6,551
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S2
|
$203,848
|
$6,115
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S3
|
$86,197
|
$2,586
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
$65,100
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vanderbilt Training Program in Molecular and Genetic Epidemiology of Cancer
|
5T32CA160056-08
|
$435,520
|
|
SHU, XIAO-OU
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-06
|
$503,410
|
$25,171
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of Siglec-6 as a novel target for cancer immunotherapy
|
1R21CA229961-01
|
$246,464
|
|
RADER, CHRISTOPH
|
SCRIPPS FLORIDA
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
4UH3CA206124-03
|
$423,750
|
$423,750
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Validation of a novel, adjuvant implant for post-metastatic skeletal lesions
|
1R43CA221553-01A1
|
$299,958
|
|
MARGULIES, BRYAN
|
FUSOLOGICS, LLC
|
|
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity
|
1R33CA217702-01A1
|
$364,966
|
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Validating and targeting USP35 for anticancer drug development
|
1U01CA222958-01A1
|
$349,766
|
|
LIU, CHANGWEI
|
UNIVERSITY OF COLORADO DENVER
|
|
Validating and Characterizing a New Melanoma Therapeutic Target
|
5R01CA217625-02
|
$635,068
|
$635,068
|
COURTNEIDGE, SARA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$413,112
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$22,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$12,261
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$6,814
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$2,859
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UV/Vit D in radiologic technologists
|
ZIA CP010133 10416
|
$73,325
|
$14,665
|
Cahoon, Elizabeth
|
DCEG (NCI)
|
|
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy
|
1K99CA230384-01
|
$107,860
|
|
HOPKINS, BENJAMIN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Utilizing MEK Inhibition to Sensitize Microsatellite Stable Colorectal Cancer to Immune Checkpoint Therapy
|
1R01CA229259-01
|
$247,340
|
|
LIEU, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-05
|
$1,267,600
|
$25,352
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
|
5R21CA216756-02
|
$224,460
|
$224,460
|
SMALLEY, KEIRAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Using patient-derived models to understand drug responses in SCLC
|
1U01CA220323-01A1
|
$619,923
|
|
DYSON, NICHOLAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Using Functional Genomics to Inform Gene Environment Interactions for Colorectal Cancer
|
3R01CA201407-02S1
|
$32,686
|
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Melanoma for this search: $184,147,651
|